Science

1. 2024–2026
   Johnson & Johnson

   Therapeutics Discovery, Cell & Genetic Medicines, Serotiny Group
2. 2014–2024
   Serotiny

   Co-founder & CTO; acquired by J&J
3. 2008–2014
   UCSF

   PhD, Biochemistry — Gartner Lab, Tetrad Graduate Program
4. 2003–2007
   Indiana University

   B.S., Chemistry · B.A., Philosophy